Gilead’s patent for Sofosbuvir was rejected by the Indian Patent Office on grounds of insufficient therapeutic efficacy. This landmark decision enables wider access to affordable generic Hepatitis C treatments in India.
Read more about ‘Killead’s Patent Application Killed by the Indian Patent Office!Dr. Kalyan delivers a lecture on “Privacy & IT Act – Relevance to Industry” at Bosch
On the occasion of International Data Privacy Day on January 28th, 2015, Dr. Kalyan was invited by Bosch, a global engineering and electronics major, to...
Read more about Dr. Kalyan delivers a lecture on “Privacy & IT Act – Relevance to Industry” at BoschDr. Kalyan interviewed by Bar & Bench about Pirates of Bollywood
Dr. Kalyan, Managing Partner, BananaIP , was recently interviewed by Bar & Bench about his latest legal thriller “Pirates of Bollywood”. Commenting on why he...
Read more about Dr. Kalyan interviewed by Bar & Bench about Pirates of BollywoodPatents: EVENT- IBC Legal’s 23rd Annual Biotech and Pharmaceutical patenting conference
Date: 24- 25 February 2015 Venue: Munich, Germany Agenda: The event designed to help you protect, maximise and grow your...
Read more about Patents: EVENT- IBC Legal’s 23rd Annual Biotech and Pharmaceutical patenting conferenceIntellectual Property: EVENT- The Grand Masters 2015- In House Counsel Legal Best Practices Summit
Date and Venue : 20 February 2015- Leela Palace, Mumbai 27 February 2015- Le Meridien, Bangalore Agenda: ...
Read more about Intellectual Property: EVENT- The Grand Masters 2015- In House Counsel Legal Best Practices SummitPirates of Bollywood on Copyright Infringement
This excerpt from Pirates of Bollywood presents a legal debate on copyright infringement involving technology platforms and indirect liability. The counsels discuss the balance between creative freedom and protecting creators’ rights in India.
Read more about Pirates of Bollywood on Copyright InfringementRoche’s backbone rendered brittle by Indian Patent Office
The Indian Patent Office has revoked Roche’s patent on Bonviva after Cipla challenged its validity, citing a lack of inventive step and patentability. This decision highlights critical aspects of Indian pharmaceutical patent law and its impact on international drug companies.
Read more about Roche’s backbone rendered brittle by Indian Patent OfficeWeekly IP Warm-UP!
Weekly IP Warm-UP covers notable intellectual property law updates, including copyright and patent litigation, music industry developments, and trade secrets cases. The post analyses recent legal changes and court decisions with clarity and factual accuracy.
Read more about Weekly IP Warm-UP!Terror Attack on the Creative Community
The Charlie Hebdo attack in Paris in January 2015 left a lasting impact on the creative community, bringing attention to the risks faced by those championing free expression. This post analyses the incident’s significance and commemorates the contributions of the victims to global creativity.
Read more about Terror Attack on the Creative CommunityDrug Humira turns Rheumatic for Abbott Biotechnology
The Indian Patent Office set aside Abbott Biotechnology’s Humira patent after Glenmark’s pre-grant opposition, citing lack of inventive step and insufficient disclosure. This legal dispute underscores ongoing challenges to Humira patents both in India and globally.
Read more about Drug Humira turns Rheumatic for Abbott Biotechnology